Neumora Therapeutics Inc....

NASDAQ: NMRA · Real-Time Price · USD
1.62
0.04 (2.53%)
At close: Aug 15, 2025, 3:59 PM
1.66
2.47%
After-hours: Aug 15, 2025, 07:51 PM EDT

Neumora Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-243.79M -235.93M -130.9M -237.31M
Depreciation & Amortization
n/a 668K 594K 538K
Stock-Based Compensation
39.99M 17.24M 8.3M 4.27M
Other Working Capital
19.76M -8.32M -5.7M -202K
Other Non-Cash Items
-1.77M 63.64M 15.35M 158.09M
Deferred Income Tax
n/a n/a -1.28M -53K
Change in Working Capital
22.64M -8.9M -6.95M -961K
Operating Cash Flow
-182.94M -163.28M -114.9M -75.42M
Capital Expenditures
n/a -117K -511K -817K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-312.22M -109.07M -226.37M n/a
Sales Maturities Of Investments
242.44M 178.17M 71.87M n/a
Other Investing Acitivies
-775K -4.59M -13M n/a
Investing Cash Flow
-70.56M 64.39M -168.01M -817K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -491K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.91M -948K 3.53M 1.37M
Financial Cash Flow
21.6M 231.94M 115.74M 293.51M
Net Cash Flow
-231.89M 133.04M -167.17M 217.27M
Free Cash Flow
-182.94M -163.4M -115.41M -76.24M